CCL3 and myeloid sarcoma: Several chemokines and their receptors, including CCR7 and its ligands (CCL19 and CCL21) and the CCL3/CCR5 receptor ligand system have been implicated in the migration of DCs into the CNS, primarily based on EAE studies and clinical data from MS patients [51]-[53].